# AliveCor

> AliveCor is a Mountain View, California digital health company that pioneered the personal, FDA-cleared electrocardiogram (ECG). Its Kardia line of pocket-sized devices lets people record a medical-grade ECG on a smartphone in about 30 seconds, while AI algorithms screen for atrial fibrillation and other arrhythmias. Combining hardware, a subscription care service, and enterprise cardiology programs, AliveCor has recorded well over 160 million ECGs for millions of users and works with clinicians, employers, health systems, and pharmaceutical researchers.

- **Founded:** 2011
- **Headquarters:** Mountain View, California, United States
- **Founders:** David Albert (Founder & Chief Medical Officer), Bruce Satchwell (Co-founder), Kim Barnett (Co-founder)
- **Team size:** Approximately 150 employees
- **Products:** AliveCor iPhone ECG / KardiaMobile, KardiaMobile 6L, KardiaCare, KardiaMobile Card, KardiaComplete
- **Notable:** Created the first FDA-cleared personal smartphone ECG (2012)., Launched the first FDA-cleared six-lead personal ECG, KardiaMobile 6L (2019)., Recorded more than 160 million ECGs for millions of users worldwide.

## Products & services

- **AliveCor iPhone ECG / KardiaMobile** — The original FDA-cleared single-lead ECG that attaches to or pairs with a smartphone, recording a medical-grade tracing in about 30 seconds and screening for AFib and normal sinus rhythm.
- **KardiaMobile 6L** — The first FDA-cleared six-lead personal ECG device, giving a fuller view of the heart's electrical activity than single-lead recorders.
- **KardiaCare** — A digital health subscription that provides advanced ECG determinations, monthly heart reports, medication and symptom tracking, and clinician sharing.
- **KardiaMobile Card** — A credit-card-sized personal ECG that fits in a wallet, one of the smallest FDA-cleared ECG recorders available.
- **KardiaComplete** — An enterprise cardiovascular program that employers and health plans offer to members, combining devices, coaching, and remote cardiac care.
- **Kardia 12L ECG System** — An AI-powered system that reconstructs a 12-lead ECG for clinical and research use, extending Kardia into professional settings.
- **KardiaMobile 6L Max & KardiaAlert** — The latest six-lead device paired with KardiaAlert, which compares each ECG to a personal baseline to flag subtle changes, and identifies up to 20 arrhythmias with clinician review.

## Achievements

- Created the first FDA-cleared personal smartphone ECG (2012).
- Launched the first FDA-cleared six-lead personal ECG, KardiaMobile 6L (2019).
- Recorded more than 160 million ECGs for millions of users worldwide.
- Won an ITC Final Determination in 2022 finding the Apple Watch infringed AliveCor ECG patents, upheld through presidential review in early 2023.
- Earned FDA Breakthrough Device Designation for its Kardia-K AI potassium-screening platform.
- Sold more than three million personal ECG devices.

## Latest updates

- **2025-05** — Launched the AI-powered KardiaMobile 6L Max and KardiaAlert, which compares each ECG against a personal baseline and detects up to 20 arrhythmias with clinician review.
- **2025-03** — U.S. Court of Appeals for the Federal Circuit ruled in Apple's favor on the underlying patent validity question, a setback in AliveCor's long-running ECG patent dispute.
- **2024** — Introduced the Kardia 12L AI-powered 12-lead ECG system, extending the platform into professional and clinical settings.
- **2022-08** — Closed a Series F financing led by GE Healthcare to expand its ECG and enterprise cardiovascular offerings.

## Links

- Website: https://alivecor.com
- LinkedIn: https://www.linkedin.com/company/alivecor
- Twitter/X: https://twitter.com/alivecor
- YouTube: https://www.youtube.com/user/AliveCor
- Instagram: https://www.instagram.com/alivecor/
- Facebook: https://facebook.com/AliveCor/

---

Profile page: https://yespress.io/alivecor
Published by YesPress — https://yespress.io
Last updated: 2026-07-14